欧舒丹(00973.HK)曾急涨10%突破牛熊线全年多赚23%获花旗及大和升价至18.4元及19元
欧舒丹(00973.HK)全年多赚23%及净销售也增逾8%,花旗绩後升欧舒丹目标价12%至18.4元,重申「买入」评级,大和升欧舒丹评级至「买入」及上调目标价至19元,该股今天一举升破五条移动平均线(250天及100天线分别为14.26元及14.32元),最多急涨10%高见15.2元,现造14.86元,急涨7.7%,成交额增至1,477万元。
欧舒丹昨天收市後公布,截至3月底止全年纯利按年增近23%至1.18亿欧元,每股盈利0.081欧元,末期股息维持0.0297欧元。期内,销售净额按年升8.1%至14.27亿欧元;毛利率维持83.2%。全年零售点总数按年增加135间或4.1%至3,420间;按固定汇率计算,可比较店铺、不可比较店铺及其他及转售分部销售按年分别增长1.8%、26.1%及6.5%。管理层预计本财年全球(香港除外)开设30-35间分店。此外,香港去年度同店销售受累於第三四季录得负2.6%增长,但料今年度同店销售有机会恢复正增长。
野村绩後上调欧舒丹未来两财年盈测6%及5%,以反映公司销售表现改善。不过,由於同店销售表现仍乏善可陈,将目标价降至14.5元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.